Marcus Low

1.1k total citations
9 papers, 233 citations indexed

About

Marcus Low is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Marcus Low has authored 9 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 2 papers in Virology and 2 papers in Emergency Medicine. Recurrent topics in Marcus Low's work include HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (2 papers). Marcus Low is often cited by papers focused on HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (2 papers). Marcus Low collaborates with scholars based in South Africa, United States and Belgium. Marcus Low's co-authors include Erik De Clercq, Rudi Pauwels, Miklós Nagy, Masanori Baba, Sándor Gǒrög, Dominique Schols, Suerie Moon, Steven G. Morgan, Fátima Suleman and Jan Balzarini and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, BMJ and Expert Review of Anti-infective Therapy.

In The Last Decade

Marcus Low

8 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Low South Africa 5 101 82 60 50 46 9 233
George Hoke United States 12 116 1.1× 81 1.0× 187 3.1× 41 0.8× 199 4.3× 17 452
Anna Laura Ross Switzerland 7 210 2.1× 119 1.5× 201 3.4× 9 0.2× 81 1.8× 14 364
Katherine Harvey Australia 11 47 0.5× 109 1.3× 62 1.0× 14 0.3× 104 2.3× 21 502
Shoya Iwanami Japan 10 258 2.6× 47 0.6× 18 0.3× 9 0.2× 39 0.8× 23 351
Daniel Perez‐Zsolt Spain 11 152 1.5× 43 0.5× 44 0.7× 16 0.3× 108 2.3× 17 348
S Shojaee Iran 12 53 0.5× 149 1.8× 62 1.0× 5 0.1× 68 1.5× 41 377
F Fazely United States 9 164 1.6× 104 1.3× 178 3.0× 30 0.6× 82 1.8× 17 356
Pedro Borrego Portugal 13 197 2.0× 86 1.0× 279 4.7× 15 0.3× 82 1.8× 32 408
C. M. Nielsen Denmark 9 143 1.4× 118 1.4× 213 3.5× 38 0.8× 80 1.7× 16 364
C Bonhomme France 10 99 1.0× 94 1.1× 7 0.1× 7 0.1× 48 1.0× 16 278

Countries citing papers authored by Marcus Low

Since Specialization
Citations

This map shows the geographic impact of Marcus Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Low more than expected).

Fields of papers citing papers by Marcus Low

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Low. The network helps show where Marcus Low may publish in the future.

Co-authorship network of co-authors of Marcus Low

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Low. A scholar is included among the top collaborators of Marcus Low based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Low. Marcus Low is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Herrera, Rosa María Blanca, Marcus Low, Lindsay McKenna, et al.. (2023). Shorter TB treatment regimens should be safer as well. Public Health Action. 13(3). 104–106. 6 indexed citations
2.
Suleman, Fátima, Marcus Low, Suerie Moon, & Steven G. Morgan. (2020). New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines. BMJ. 368. l4408–l4408. 27 indexed citations
3.
Guglielmetti, Lorenzo, Marcus Low, & Lindsay McKenna. (2020). Challenges in TB regimen development: preserving evidentiary standards for regulatory decisions and policymaking. Expert Review of Anti-infective Therapy. 18(8). 701–704. 4 indexed citations
4.
Geffen, Nathan & Marcus Low. (2017). When to start antiretroviral treatment? A history and analysis of a scientific controversy. Southern African Journal of HIV Medicine. 18(1). 734–734. 7 indexed citations
5.
Geffen, Nathan, et al.. (2014). One size doesn’t fit all: Tailoring adult antiretroviral treatment. Southern African Journal of HIV Medicine. 15(3). 77–78. 2 indexed citations
6.
Geffen, Nathan, et al.. (2014). One size doesn’t fit all: Tailoring adult antiretroviral treatment. Southern African Journal of HIV Medicine. 15(3). 77–77. 3 indexed citations
8.
Baba, Masanori, Dominique Schols, Erik De Clercq, et al.. (1990). Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation. Antimicrobial Agents and Chemotherapy. 34(1). 134–138. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026